These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24117282)

  • 1. Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome.
    Brezinova J; Sarova I; Buryova H; Markova J; Ransdorfova S; Izakova S; Kostylkova K; Soukupova J; Zemanova Z; Michalova K
    Br J Haematol; 2014 Jan; 164(1):153-5. PubMed ID: 24117282
    [No Abstract]   [Full Text] [Related]  

  • 2. ASXL1 gene alterations in patients with isolated 20q deletion.
    Brezinova J; Sarova I; Svobodova K; Lhotska H; Ransdorfova S; Izakova S; Pavlistova L; Lizcova L; Skipalova K; Hodanova L; Markova J; Zemanova Z; Cermak J; Jonasova A; Michalova K
    Neoplasma; 2019 Jul; 66(4):627-630. PubMed ID: 30868899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
    Mullier F; Daliphard S; Garand R; Dekeyser M; Cornet Y; Luquet I; Talmant P; Richebourg S; Jamar M; Dogné JM; Chatelain C; Michaux L; Chatelain B
    Ann Hematol; 2012 Feb; 91(2):203-13. PubMed ID: 21744002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
    Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
    Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome.
    Douet-Guilbert N; Laï JL; Basinko A; Gueganic N; Andrieux J; Pollet B; Plantier I; Delattre C; Crépin O; Corm S; Le Bris MJ; Morel F; De Braekeleer M
    Br J Haematol; 2008 Dec; 143(5):716-20. PubMed ID: 19036015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited.
    Liu YC; Ito Y; Hsiao HH; Sashida G; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Nov; 171(1):9-16. PubMed ID: 17074585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
    Li T; Xue Y; Wu Y; Pan J
    Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
    Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
    Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].
    Qin S; Liu SH; Bo LJ; Liu XP; Li CW; Dai Y; He GS; Shao ZH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):171-2. PubMed ID: 15079804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic syndrome with ider(20q) and prominent emperipolesis.
    Wong E; Juneja S
    Ann Hematol; 2014 Feb; 93(2):341-2. PubMed ID: 23732442
    [No Abstract]   [Full Text] [Related]  

  • 13. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.
    Bernasconi P; Klersy C; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Caresana M; Dambruoso I; Lazzarino M; Bernasconi C
    Br J Haematol; 2007 May; 137(3):193-205. PubMed ID: 17408458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double 20q- anomaly in myelodysplastic syndrome.
    Ohyashiki K; Murakami T; Ohyashiki JH; Kodama A; Sakai N; Ito H; Toyama K
    Cancer Genet Cytogenet; 1992 Feb; 58(2):174-6. PubMed ID: 1551084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
    Bacher U; Haferlach T; Schnittger S; Zenger M; Meggendorfer M; Jeromin S; Roller A; Grossmann V; Krauth MT; Alpermann T; Kern W; Haferlach C
    Br J Haematol; 2014 Mar; 164(6):822-33. PubMed ID: 24372512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
    Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
    Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study.
    Falzetti D; Vermeesch JR; Hood TL; Nacheva EP; Matteucci C; Martelli MF; Van den Berghe H; Marynen P; Mecucci C
    Leuk Res; 1999 Apr; 23(4):407-13. PubMed ID: 10229328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies.
    MacKinnon RN; Campbell LJ
    Cancer Genet Cytogenet; 2005 Dec; 163(2):176-9. PubMed ID: 16337864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-).
    Li T; Xue Y; Wu Y; Pan J
    Br J Haematol; 2004 May; 125(3):337-42. PubMed ID: 15086414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.